| | | | | |
ANIK Anika Therapeutics Inc | $21,3980 | -0,80 % | $294,82M | $27,40K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10,4960 | +0,15 % | $294,73M | $1,09K | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | $10,0150 | -0,25 % | $294,68M | $407,00 | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | $42,8500 | -0,72 % | $294,53M | $4,93K | |
| $44,5150 | -1,41 % | $294,35M | $4,50K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | $10,0200 | +0,20 % | $294,35M | $6,000 | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | $10,0790 | -0,01 % | $294,33M | $318,00 | |
SLN Silence Therapeutics Plc American Depository Share | $13,8360 | -1,87 % | $294,27M | $222,32K | |
MTNE CH4 Natural Solutions Corporation | $9,8750 | +0,04 % | $293,88M | $6,000 | |
RXST RxSight, Inc. Common Stock | $6,4250 | +0,86 % | $293,64M | $130,50K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | $10,6300 | -0,19 % | $293,52M | $36,86K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | $10,0100 | +0,05 % | $293,49M | $56,36K | |
CNXU Conexeu Sciences Inc. Common Stock | $8,7500 | -12,40 % | $293,27M | $198,38K | |
| $10,3910 | +4,01 % | $292,98M | $368,19K | |
JCE Nuveen Core Equity Alpha Fund | $17,1650 | +0,50 % | $292,78M | $5,90K | |
